Search Results 2001-2010 of 17013 for monoclonal antibody

1. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

   treatment. 3. Received at least 3 prior therapies (including proteasome inhibitor, immune modulatory drug, and an anti-CD38 antibody; patients should not be a ...

2. Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases - Mayo Clinic

   For patients that received antibodies the washout period is 4 weeks prior to study treatment. History of hypersensitivity to the study treatment or its ...

3. Phase 2a Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis - Mayo Clinic

   HIV infection, defined as confirmed positive HIV antigen/antibody at screening. Positive for drugs in the urine drug screen without documented medical ...

4. A Study to Determine the Safety of PEP in Skin Graft Wounds - Mayo Clinic

   Subjects who are positive for hepatitis B surface antigen (HbsAg), hepatitis C antibody or HIV. Any known allergy or sensitivity to adhesive dressings (e.g. ...

5. Mayo Clinic Clinical Trial Helps Physician Take On Multiple Myeloma

   He had known he was at a greater risk for contracting multiple myeloma for many years because of a condition called monoclonal gammopathy of undetermined ...

6. Mayo Clinic Physicians to Present Research Findings From Late-breaking Transplant Studies at American Transplant Congress

   “Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost Differential in Treatment of AMR” · Mayo Clinic surgeons at ...

7. Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC - Mayo Clinic

   History of severe allergic anaphylactic reactions to chimeric or humanized antibodies or fusion proteins. 8. History of idiopathic pulmonary fibrosis ...

8. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES) - Mayo Clinic

   ... antibody) or other stable chronic liver disease are acceptable if patient otherwise meets eligibility criteria. Stable chronic liver disease should ...

9. 24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Adults With PMM2-CDG - Mayo Clinic

   ... antibody during Screening; - Has history or presence, upon clinical evaluation, of any illness that might impact the safety of GLM101 infusion or ...

10. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    Anti-adenovirus serotype 5 neutralizing antibody titer < 1:320. Adequate hematologic function defined as hemoglobin ≥ 10 g/dL, absolute neutrophil count > ...